Molecular Mechanisms of Cancer Progression and Recurrence
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 177
Special Issue Editor
Interests: cancer (urogenital, ovarian, haematological); endocrinology; autoimmunity; immunology; genomics; proteomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a multifaceted disease that involves not just appearance at a single body site, but rather has the potential of spreading throughout body organs through the metastasis process. In addition to that, it poses a number of problems in its treatment, and recurrence is a harsh reality for this disease. Factors within the tumor microenvironment play key roles in the process of recurrence and metastasis. These factors include stroma cells and extracellular matrices. Deregulated processes, due to factors such as genetic mutations, including angiogenesis, tumor suppression, repair mechanisms and cell cycle, contribute to the so-called cancer phenotype.
The aim of this Special Issue is to provide a collection of research articles, research letters and reviews that deal with the molecular mechanisms of cancer progression and recurrence. The submitted papers may cover any aspect of cancer biology that deals with these issues (not leaving out the interplay with the immune system). Papers that refer to clinical processes based on targeting any cancer progression and recurrence mechanism will be considered too.
Dr. Nikos G. Gavalas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- metastasis
- angiogenesis
- recurrence
- clinical
- molecular
- mechanisms
- mutations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
